Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction
(Q58874452)
scientific article published on 01 October 1998
scientific article published on 01 October 1998
Language:
Current Data About
Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction
other details
| description | scientific article published on 01 October 1998 |
External Links
| (P356) |
10.1093/JAC/42.4.535
|
| (P698) |
9818756
|